Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems

Antimicrobial peptides (AMPs) are natural biopolymers in the host defense system. AMPs display multiple functions against bacterial, fungal, and viral infection, as well as anticancer properties. AMPs are promising antiviral and anticancer agents. The average size, net charge, and hydrophobicity res...

Full description

Bibliographic Details
Main Authors: Ming Yang, Shuai Liu, Chunye Zhang
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:Current Research in Biotechnology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590262823000035
_version_ 1827918490104758272
author Ming Yang
Shuai Liu
Chunye Zhang
author_facet Ming Yang
Shuai Liu
Chunye Zhang
author_sort Ming Yang
collection DOAJ
description Antimicrobial peptides (AMPs) are natural biopolymers in the host defense system. AMPs display multiple functions against bacterial, fungal, and viral infection, as well as anticancer properties. AMPs are promising antiviral and anticancer agents. The average size, net charge, and hydrophobicity residue percentage of these AMPs in the Antimicrobial Peptide Database (APD) are 26 amino acids, 3.5 (+), and 48 %, respectively. However, pharmacokinetic disadvantages such as low proteolytic and chemical stability, high cytotoxicity and hemolytic activity, and salt sensitivity inhibit their clinical application. Given the promising effects of AMPs on antiviral and anticancer features, circumventing the drawbacks of AMPs and improving their efficacy are critically important for clinical application. The structure and amino acid components of AMPs can be modified by several methods, including stabilization, hybridization, cyclization, fragmentation, multimerization, alteration of amino acids, and conjugation or ligation. Furthermore, nanotechnologies are effective tools or strategies to improve their functions and reduce side effects. For example, melittin-nano conjugation can improve its therapeutic efficacy and minimize nonspecific cytotoxicity. Clinical trials are waiting to evaluate the efficacy of the delivery system and novel AMPs in antiviral and anticancer treatments.
first_indexed 2024-03-13T03:43:19Z
format Article
id doaj.art-2a201cf2e5f042fcbc887ea992bf0c75
institution Directory Open Access Journal
issn 2590-2628
language English
last_indexed 2024-03-13T03:43:19Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series Current Research in Biotechnology
spelling doaj.art-2a201cf2e5f042fcbc887ea992bf0c752023-06-23T04:44:01ZengElsevierCurrent Research in Biotechnology2590-26282023-01-015100121Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systemsMing Yang0Shuai Liu1Chunye Zhang2Department of Surgery, University of Missouri, Columbia, MO 65212, USAThe First Affiliated Hospital, Zhejiang University, Hangzhou 310006, ChinaChristopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO 65212, USA; Corresponding author.Antimicrobial peptides (AMPs) are natural biopolymers in the host defense system. AMPs display multiple functions against bacterial, fungal, and viral infection, as well as anticancer properties. AMPs are promising antiviral and anticancer agents. The average size, net charge, and hydrophobicity residue percentage of these AMPs in the Antimicrobial Peptide Database (APD) are 26 amino acids, 3.5 (+), and 48 %, respectively. However, pharmacokinetic disadvantages such as low proteolytic and chemical stability, high cytotoxicity and hemolytic activity, and salt sensitivity inhibit their clinical application. Given the promising effects of AMPs on antiviral and anticancer features, circumventing the drawbacks of AMPs and improving their efficacy are critically important for clinical application. The structure and amino acid components of AMPs can be modified by several methods, including stabilization, hybridization, cyclization, fragmentation, multimerization, alteration of amino acids, and conjugation or ligation. Furthermore, nanotechnologies are effective tools or strategies to improve their functions and reduce side effects. For example, melittin-nano conjugation can improve its therapeutic efficacy and minimize nonspecific cytotoxicity. Clinical trials are waiting to evaluate the efficacy of the delivery system and novel AMPs in antiviral and anticancer treatments.http://www.sciencedirect.com/science/article/pii/S2590262823000035Antimicrobial peptidesAnticancer activityAntiviral activityMolecular structureMechanism of actionClinical trials
spellingShingle Ming Yang
Shuai Liu
Chunye Zhang
Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
Current Research in Biotechnology
Antimicrobial peptides
Anticancer activity
Antiviral activity
Molecular structure
Mechanism of action
Clinical trials
title Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
title_full Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
title_fullStr Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
title_full_unstemmed Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
title_short Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
title_sort antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems
topic Antimicrobial peptides
Anticancer activity
Antiviral activity
Molecular structure
Mechanism of action
Clinical trials
url http://www.sciencedirect.com/science/article/pii/S2590262823000035
work_keys_str_mv AT mingyang antimicrobialpeptideswithantiviralandanticancerpropertiesandtheirmodificationandnanodeliverysystems
AT shuailiu antimicrobialpeptideswithantiviralandanticancerpropertiesandtheirmodificationandnanodeliverysystems
AT chunyezhang antimicrobialpeptideswithantiviralandanticancerpropertiesandtheirmodificationandnanodeliverysystems